Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes

5 mg IV twice a week for 4 weeks

25 mg IV twice a week for 4 weeks

100 mg IV twice a week for 4 weeks

200 mg IV twice a week for 4 weeks

0.9% w/v sodium chloride injection, United States Pharmacopeia (USP), twice a week IV for 4 weeks